Abstract
Ezrin is a member of the ERM (ezrin, radixin, moesin) protein family and links F-actin to the cell membrane following phosphorylation. Ezrin has been associated with tumor progression and metastasis in several cancers including the pediatric solid tumors, osteosarcoma and rhabdomyosarcoma. In this study, we were surprised to find that ezrin was not constitutively phosphorylated but rather was dynamically regulated during metastatic progression in osteosarcoma. Metastatic osteosarcoma cells expressed phosphorylated ERM early after their arrival in the lung, and then late in progression, only at the invasive front of larger metastatic lesions. To pursue mechanisms for this regulation, we found that inhibitors of PKC (protein kinase C) blocked phosphorylation of ezrin, and that ezrin coimmunoprecipitated in cells with PKCα, PKCι and PKCγ. Furthermore, phosphorylated forms of ezrin and PKC had identical expression patterns at the invasive front of pulmonary metastatic lesions in murine and human patient samples. Finally, we showed that the promigratory effects of PKC were linked to ezrin phosphorylation. These data are the first to suggest a dynamic regulation of ezrin phosphorylation during metastasis and to connect the PKC family members with this regulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berryman M, Franck Z, Bretscher A . (1993). Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105 (Part 4): 1025–1043.
Blobe GC, Obeid LM, Hannun YA . (1994). Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev 13: 411–431.
Bornancin F, Parker PJ . (1997). Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J Biol Chem 272: 3544–3549.
Bretscher A, Chambers D, Nguyen R, Reczek D . (2000). ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 16: 113–143.
Bretscher A, Edwards K, Fehon RG . (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3: 586–599.
Bretscher A, Reczek D, Berryman M . (1997). Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci 110 (Part 24): 3011–3018.
Brown MJ, Nijhara R, Hallam JA, Gignac M, Yamada KM, Erlandsen SL et al. (2003). Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 102: 3890–3899.
Bruce B, Khanna G, Ren L, Landberg G, Jirstrom K, Powell C et al. (2007). Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis 24: 69–78.
Cant SH, Pitcher JA . (2005). G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. Mol Biol Cell 16: 3088–3099.
Chuan YC, Pang ST, Cedazo-Minguez A, Norstedt G, Pousette A, Flores-Morales A . (2006). Androgen induction of prostate cancer cell invasion is mediated by ezrin. J Biol Chem 281: 29938–29948.
Dard N, Louvet-Vallee S, Santa-Maria A, Maro B . (2004). Phosphorylation of ezrin on threonine T567 plays a crucial role during compaction in the mouse early embryo. Dev Biol 271: 87–97.
Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M . (2005). The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 7: R365–R373.
Fievet BT, Gautreau A, Roy C, Del Maestro L, Mangeat P, Louvard D et al. (2004). Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. J Cell Biol 164: 653–659.
Forte E, Orsatti L, Talamo F, Barbato G, De Francesco R, Tomei L . (2008). Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Biochim Biophys Acta 1783: 334–344.
Gautreau A, Louvard D, Arpin M . (2000). Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J Cell Biol 150: 193–203.
Herbert JM . (1993). Protein kinase C: a key factor in the regulation of tumor cell adhesion to the endothelium. Biochem Pharmacol 45: 527–537.
Hishiya A, Ohnishi M, Tamura S, Nakamura F . (1999). Protein phosphatase 2C inactivates F-actin binding of human platelet moesin. J Biol Chem 274: 26705–26712.
Ilmonen S, Vaheri A, Asko-Seljavaara S, Carpen O . (2005). Ezrin in primary cutaneous melanoma. Mod Pathol 18: 503–510.
Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C et al. (2001). Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61: 3750–3759.
Khanna C, Prehn J, Yeung C, Caylor J, Tsokos M, Helman L . (2000). An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp Metastasis 18: 261–271.
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A et al. (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182–186.
Kivela T, Jaaskelainen J, Vaheri A, Carpen O . (2000). Ezrin, a membrane-organizing protein, as a polarization marker of the retinal pigment epithelium in vertebrates. Cell Tissue Res 301: 217–223.
Kobel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, Lantzsch T et al. (2006). Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol 25: 121–130.
Koivunen J, Aaltonen V, Koskela S, Lehenkari P, Laato M, Peltonen J . (2004). Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Res 64: 5693–5701.
Krieg J, Hunter T . (1992). Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem 267: 19258–19265.
Krishnan K, Bruce B, Hewitt S, Thomas D, Khanna C, Helman LJ . (2006). Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway. Clin Exp Metastasis 23: 227–236.
Makitie T, Carpen O, Vaheri A, Kivela T . (2001). Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 42: 2442–2449.
Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K et al. (1998). Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 140: 647–657.
Matsui T, Yonemura S, Tsukita S . (1999). Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases. Curr Biol 9: 1259–1262.
Musashi M, Ota S, Shiroshita N . (2000). The role of protein kinase C isoforms in cell proliferation and apoptosis. Int J Hematol 72: 12–19.
Nakamura N, Oshiro N, Fukata Y, Amano M, Fukata M, Kuroda S et al. (2000). Phosphorylation of ERM proteins at filopodia induced by Cdc42. Genes Cells 5: 571–581.
Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, Gautreau A et al. (2001). Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J 20: 2723–2741.
Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, Naftolin F . (1999). Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 147: 31–38.
Oshiro N, Fukata Y, Kaibuchi K . (1998). Phosphorylation of moesin by rho-associated kinase (Rho-kinase) plays a crucial role in the formation of microvilli-like structures. J Biol Chem 273: 34663–34666.
Pang ST, Fang X, Valdman A, Norstedt G, Pousette A, Egevad L et al. (2004). Expression of ezrin in prostatic intraepithelial neoplasia. Urology 63: 609–612.
Pearson MA, Reczek D, Bretscher A, Karplus PA . (2000). Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101: 259–270.
Pietromonaco SF, Simons PC, Altman A, Elias L . (1998). Protein kinase C-theta phosphorylation of moesin in the actin-binding sequence. J Biol Chem 273: 7594–7603.
Polesello C, Payre F . (2004). Small is beautiful: what flies tell us about ERM protein function in development. Trends Cell Biol 14: 294–302.
Reczek D, Berryman M, Bretscher A . (1997). Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 139: 169–179.
Saotome I, Curto M, McClatchey AI . (2004). Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 6: 855–864.
Serrador JM, Nieto M, Sanchez-Madrid F . (1999). Cytoskeletal rearrangement during migration and activation of T lymphocytes. Trends Cell Biol 9: 228–233.
Simons PC, Pietromonaco SF, Reczek D, Bretscher A, Elias L . (1998). C-terminal threonine phosphorylation activates ERM proteins to link the cell's cortical lipid bilayer to the cytoskeleton. Biochem Biophys Res Commun 253: 561–565.
Srivastava J, Elliott BE, Louvard D, Arpin M . (2005). Src-dependent ezrin phosphorylation in adhesion-mediated signaling. Mol Biol Cell 16: 1481–1490.
Sullivan RM, Stone M, Marshall JF, Uberall F, Rotenberg SA . (2000). Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells. Mol Pharmacol 58: 729–737.
Tsukita S, Oishi K, Sato N, Sagara J, Kawai A . (1994). ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391–401.
Wald FA, Oriolo AS, Mashukova A, Fregien NL, Langshaw AH, Salas PJ . (2008). Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells. J Cell Sci 121 (Part 5): 644–654.
Weng WH, Ahlen J, Astrom K, Lui WO, Larsson C . (2005). Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 11: 6198–6204.
Wu KL, Khan S, Lakhe-Reddy S, Jarad G, Mukherjee A, Obejero-Paz CA et al. (2004). The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J Biol Chem 279: 26280–26286.
Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, Tsukita S . (1998). Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 140: 885–895.
Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G . (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10: 175–181.
Zhu L, Zhou R, Mettler S, Wu T, Abbas A, Delaney J et al. (2007). High turnover of ezrin T567 phosphorylation: conformation, activity, and cellular function. Am J Physiol Cell Physiol 293: C874–C884.
Acknowledgements
We would like to thank Drs Joseph Briggs and Luowei Li for experimental advice and their critical review of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Ren, L., Hong, S., Cassavaugh, J. et al. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 28, 792–802 (2009). https://doi.org/10.1038/onc.2008.437
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.437
Keywords
This article is cited by
-
Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer
Breast Cancer Research (2019)
-
PI3Kα isoform-dependent activation of RhoA regulates Wnt5a-induced osteosarcoma cell migration
Cancer Cell International (2017)
-
Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
Oncogene (2017)
-
Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma
Journal of Orthopaedic Surgery and Research (2016)
-
Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer cells through ERM activation
Scientific Reports (2016)